Please use our
Advanced Search to narrow down your search.
The current month's archives are listed below. For others, click on the link on the left side.
Note: You will need to login first to read archives.
24 January 2011
Chelsea accelerates Northera NDA filing following meeting with US FDA ...more US FDA and Health Canada grant priority reviews for Vertex's Telaprevir in Hepatitis C ...more Sanofi-aventis extends tender offer to acquire Genzyme shares ...more Forest Labs, Pierre Fabre announce topline phase III study results of levomilnacipran for MDD treatment ...more Soligenix gets US FDA orphan drug status for RiVax for prevention of ricin intoxication ...more MedImmune's preclinical results on MEDI-573 show it broadly suppresses pathways that regulate development & progression of cancer ...more Repligen licenses rights to use of HDAC3 inhibitors for memory disorders ...more Nonin Medical launches new WristOx2, Model 3150 wrist-worn pulse oximeter in US & Canada ...more MMIS launches MediSpend aggregate spend reporting solution ...more Cellectis acquires exclusive license to TAL effector patents from University of Minnesota ...more Health ministry finalizes Biomedical Research Bill with several new features ...more India raise concern over WHO’s failure to replace IMPACT with working group on counterfeit drugs ...more Gujarat FDCA asks drug cos to be ready to make ribavirin, in case of fever outbreak ...more Karnataka DC proposes 18 centres for pharmacovigilance at govt medical college hospitals ...more ADMA seeks exemption from FMRAI's demands, urges Ayush dept to intervene ...more
22 January 2011
Genzyme to build €250 million additional manufacturing plant in Belgium ...more Cytori presents data demonstrating statistically significant reduction in ventricular tachyarrhythmias ...more Mylan's Matrix gets tentative US FDA nod under PEPFAR for Lamivudine & Zidovudine tabs ...more Novo Nordisk, Emisphere enter licence agreement to develop oral formulation of insulin for diabetes ...more NeoStem completes acquisition of Progenitor Cell Therapy ...more Chelsea reports data demonstrating sustained symptomatic benefit of Northera in NOH ...more Merck KgaA, Lead Discovery Centre enter agreement for anti-cancer compounds discovery ...more Perrigo to acquire assets of Paddock Labs for $540 million ...more Govt constitutes Evaluation Committee to screen & approve applications for stem cell therapy ...more EU still pushing data exclusivity through FTA, India stands firm ...more Khoday Group ventures into stem cell therapy, research ...more ADMA wants Dept of Ayush to enhance subsidy provided under scheme nos 4, 5 ...more Indian Academy of Sciences confers fellowship on IICT scientist ...more
21 January 2011
Peregrine initiates Investigator-Sponsored Trial in HER2-negative metastatic breast cancer ...more Wockhardt launches generic version of Protonix tablets in US ...more Asynt launches new low temperature reaction system ...more Opto Circuits' German subsidiary to launch solutions for treating peripheral arterial disease ...more Adventrx Pharma receives PDUFA date for Exelbine NDA ...more INTERPHEX 2011 to be held from March 29 to 31 in New York ...more Protalix presents data on Fabry programme & oral enzyme Gaucher programme with experts ...more Boston Scientific enters pact with Fukuda Denshi for distribution of CRM products in Japan ...more Clinical trial results demonstrate promise for first non-suppressive HIV drug ...more Uluru enters agreement with Exciton to develop antimicrobial dressing ...more US FDA to improve most common review path for medical devices ...more BioMarin initiates phase I/II trial for BMN 701 to treat pompe disease ...more Boston Scientific to acquire Minnesota -based Atritech ...more Expert panel to recommend regulatory guidelines for biosimilars soon ...more India, US soon to begin research on maternal & child health and human development research ...more IIP, Mumbai planning to start B Tech course in packaging by 2012 ...more ISM units in TN seek Rajya Sabha MP's intervention to sort out major issues of Ayurveda sector ...more Dr Agarwal's Group of Eye Hospitals set to invest Rs. 50 cr for pan Karnataka foray ...more